Direct Oral Anticoagulants and Factor IIa and Xa Inhibitors

In this knowledge-based continuing pharmacy education activity Dr. LeClair and Dr. Rizal  discuss the new direct oral anticoagulants (DOACs) and Factor IIa and Xa.

Target Audience:

Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy

This activity is not accredited for technicians

Learning objectives:

At the conclusion of the activity, pharmacists will be able to:

1.  Discuss the pharmacology of the DOACs/Factor IIa and Xa inhibitors
2.  Discuss the indications and contraindications for the DOACs/Factor IIa and Xa inhibitors
3.  Review the kinetic profiles of the DOACs/Factor IIa and Xa inhibitors

Activity Faculty:

Jessica N. LeClair, PharmD, MBA
PGY-1 Pharmacy Practice Resident
John Dempsey Hospital (JDH) at UConn Health
Farmington, CT

Anuja Rizal, Pharm.D., R.Ph., CACP
Anticoagulation Clinic Coordinator
The University of Connecticut Health Center
Farmington, CT

Faculty Disclosure:

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

Program Fees:

Click on the registration link to register for this activity. The cost is $15.00 if registering separately or 13 activities for $120.00 if bundling. See registration site for details.

Grant Funding:

There is no grant funding for this activity.

ACPE logoThe University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1 contact hour (0.1 CEU) will be awarded to pharmacists who view the presentation, pass the learning assessment with a grade of 70% or better and complete an evaluation. (ACPE #0009-0000-19-020-H01-P).   All credits will be electronically submitted to CPE Monitor within 72 hours of completing the activity.

Initial release date: June 1, 2019
Planned expiration date: May 31, 2022

Disclaimer:
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.